bw 373u86 has been researched along with etorphine in 1 studies
| Studies (bw 373u86) | Trials (bw 373u86) | Recent Studies (post-2010) (bw 373u86) | Studies (etorphine) | Trials (etorphine) | Recent Studies (post-2010) (etorphine) |
|---|---|---|---|---|---|
| 80 | 0 | 4 | 12 | 0 | 1 |
| Protein | Taxonomy | bw 373u86 (IC50) | etorphine (IC50) |
|---|---|---|---|
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0074 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0001 | |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.0018 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernard, D; Coop, A; MacKerell, AD | 1 |
1 other study(ies) available for bw 373u86 and etorphine
| Article | Year |
|---|---|
Quantitative conformationally sampled pharmacophore for delta opioid ligands: reevaluation of hydrophobic moieties essential for biological activity.
Topics: Animals; Cell Line, Tumor; Enkephalin, Leucine; Hydrophobic and Hydrophilic Interactions; Ligands; Models, Molecular; Molecular Conformation; Phenylalanine; Quantitative Structure-Activity Relationship; Rats; Receptors, Opioid, delta | 2007 |